309 related articles for article (PubMed ID: 37172782)
1. Ocular immunosuppressive microenvironment and novel drug delivery for control of uveitis.
Teabagy S; Wood E; Bilsbury E; Doherty S; Janardhana P; Lee DJ
Adv Drug Deliv Rev; 2023 Jul; 198():114869. PubMed ID: 37172782
[TBL] [Abstract][Full Text] [Related]
2. Ocular immune privilege.
Taylor AW
Eye (Lond); 2009 Oct; 23(10):1885-9. PubMed ID: 19136922
[TBL] [Abstract][Full Text] [Related]
3. Ocular immune privilege in the year 2010: ocular immune privilege and uveitis.
Taylor AW; Kaplan HJ
Ocul Immunol Inflamm; 2010 Dec; 18(6):488-92. PubMed ID: 21091058
[TBL] [Abstract][Full Text] [Related]
4. Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation.
Streilein JW
J Leukoc Biol; 2003 Aug; 74(2):179-85. PubMed ID: 12885934
[TBL] [Abstract][Full Text] [Related]
5. Immune Privilege and Eye-Derived T-Regulatory Cells.
Keino H; Horie S; Sugita S
J Immunol Res; 2018; 2018():1679197. PubMed ID: 29888291
[TBL] [Abstract][Full Text] [Related]
6. Ocular immune privilege and the impact of intraocular inflammation.
Streilein JW; Ohta K; Mo JS; Taylor AW
DNA Cell Biol; 2002; 21(5-6):453-9. PubMed ID: 12167248
[TBL] [Abstract][Full Text] [Related]
7. Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye.
Streilein JW
Eye (Lond); 1995; 9 ( Pt 2)():236-40. PubMed ID: 7556724
[TBL] [Abstract][Full Text] [Related]
8. Ocular autoimmunity: the price of privilege?
Caspi RR
Immunol Rev; 2006 Oct; 213():23-35. PubMed ID: 16972894
[TBL] [Abstract][Full Text] [Related]
9. [Intraocular inflammation and homeostasis of the eye].
Mochizuki M
Nippon Ganka Gakkai Zasshi; 2009 Mar; 113(3):344-77; discussion 378. PubMed ID: 19348183
[TBL] [Abstract][Full Text] [Related]
10. Immunoregulatory mechanisms of the eye.
Streilein JW
Prog Retin Eye Res; 1999 May; 18(3):357-70. PubMed ID: 10192517
[TBL] [Abstract][Full Text] [Related]
11. IMMUNE-MEDIATED INTRAOCULAR INFLAMMATION. A REVIEW.
Klímová A; Brichová M; Říhová E; Heissigerová J; Svozílková P
Cesk Slov Oftalmol; 2021; 77(4):163-168. PubMed ID: 34507492
[TBL] [Abstract][Full Text] [Related]
12. Recent Patents and Emerging Therapeutics on Ocular Inflammation and Allergy.
Agrahari V; Aulgur Z; Thukral S; Dhall N; Conley R; Mitra AK
Recent Pat Inflamm Allergy Drug Discov; 2017; 11(2):92-106. PubMed ID: 28901856
[TBL] [Abstract][Full Text] [Related]
13. Immune privilege in the anterior chamber of the eye.
Niederkorn JY
Crit Rev Immunol; 2002; 22(1):13-46. PubMed ID: 12186187
[TBL] [Abstract][Full Text] [Related]
14. Immune Privilege: The Microbiome and Uveitis.
Mölzer C; Heissigerova J; Wilson HM; Kuffova L; Forrester JV
Front Immunol; 2020; 11():608377. PubMed ID: 33569055
[TBL] [Abstract][Full Text] [Related]
15. Tolerance Induction in Relation to the Eye.
Gery I; Caspi RR
Front Immunol; 2018; 9():2304. PubMed ID: 30356688
[TBL] [Abstract][Full Text] [Related]
16. T cells in ocular autoimmune uveitis: Pathways and therapeutic approaches.
Zhang M; Zhang X
Int Immunopharmacol; 2023 Jan; 114():109565. PubMed ID: 36535124
[TBL] [Abstract][Full Text] [Related]
17. Immune Relevant Models for Ocular Inflammatory Diseases.
Gilger BC
ILAR J; 2018 Dec; 59(3):352-362. PubMed ID: 29474707
[TBL] [Abstract][Full Text] [Related]
18. Immunological homeostasis of the eye.
Mochizuki M; Sugita S; Kamoi K
Prog Retin Eye Res; 2013 Mar; 33():10-27. PubMed ID: 23108335
[TBL] [Abstract][Full Text] [Related]
19. Resolution of uveitis.
Wildner G; Diedrichs-Möhring M
Semin Immunopathol; 2019 Nov; 41(6):727-736. PubMed ID: 31591678
[TBL] [Abstract][Full Text] [Related]
20. IMMUNE-MEDIATED INTRAOCULAR INFLAMMATION. A REVIEW.
Klímová A; Brichová M; Říhová E; Heissigerová J; Svozílková P
Cesk Slov Oftalmol; 2020; 1(Ahead of print):1-6. PubMed ID: 34724793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
